Cohere Health and Humana Expand Prior Authorization Partnership, Adding Diagnostic Imaging and Sleep Services

Go back to Cohere Health and Humana Expand Prior Authorization Partnership, Adding Diagnostic Imaging and Sleep Services

Humana (HUM) PT Lowered to $353 at RBC Capital

April 25, 2024 6:44 AM EDT

RBC Capital analyst Frank Morgan lowered the price target on Humana (NYSE: HUM) to $353.00 (from $415.00) while maintaining a Outperform rating.

The analyst comments "Despite taking 2025 adjusted EPS growth targets off the table for now, management stressed its continued commitment to margin... More

Humana (HUM) PT Lowered to $360 at Cantor Fitzgerald

April 25, 2024 6:32 AM EDT

Cantor Fitzgerald analyst Sarah James lowered the price target on Humana (NYSE: HUM) to $360.00 (from $391.00) while maintaining a Neutral rating.

The analyst comments "On the positive side, HUM beat the quarter (expected by investors) and held 2024 guide (also expected by... More